Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vanda Pharmaceuticals

4.32
-0.1200-2.70%
Post-market: 4.26-0.0600-1.39%16:36 EDT
Volume:361.79K
Turnover:1.58M
Market Cap:254.60M
PE:-5.68
High:4.47
Open:4.41
Low:4.27
Close:4.44
Loading ...
May 05, 2022

Major Issues Report

8-K - Current report
Mar 01, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 23, 2022

Major Issues Report

8-K - Current report
Feb 15, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 04, 2022

Major Issues Report

8-K - Current report
Jan 14, 2022

Major Issues Report

8-K - Current report
Dec 02, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 13, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 23, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Aug 17, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 30, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Jul 29, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 28, 2021

Major Issues Report

8-K - Current report
Jun 10, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jun 10, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]